1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024

Summary

OA is a degenerative disease of the entire joint, which involves the cartilage, joint lining, ligaments, and underlying bone. OA is the most common form of joint disease. The most affected joints are the knee, hip, hand, and spine. The disease’s onset is gradual and typically seen in middle-aged to elderly people. OA is characterized by pain, stiffness, swelling, crepitus, and limited movement of the affected joint. OA will be the fourth leading cause of disability by the year 2020.

GlobalData epidemiologists forecast an increase in the total prevalent cases of hand OA in the 7MM from 151,439,533150,635,612 total prevalent cases in 2014 to 176,143,154175,213,683 total prevalent cases in 2024 at an AGR of 1.63% during the forecast period. GlobalData epidemiologists forecast that the total prevalent cases of knee OA in the 7MM are expected to increase from 110,840,501 total prevalent cases in 2014 to 127,929,359 total prevalent cases in 2024 at an AGR of 1.54% during the forecast period. GlobalData epidemiologists forecast that the total prevalent cases of hip OA in the 7MM are expected to increase from 61,150,916 total prevalent cases in 2014 to 69,699,696 total prevalent cases in 2024 at an AGR of 1.4% during the forecast period. The diagnosed prevalent cases of hand OA in the 7MM are expected to increase from 61,045,59060,125,229 diagnosed prevalent cases in 2014 to 70,996,37570,072,690 diagnosed prevalent cases in 2024 at an AGR of 1.635% during the forecast period. The diagnosed prevalent cases of knee OA in the 7MM are expected to increase from 37,845,305 diagnosed prevalent cases in 2014 to 43,877,213 diagnosed prevalent cases in 2024 at an AGR of 1.59% during the forecast period. The diagnosed prevalent cases of hip OA in the 7MM are expected to increase from 15,116,094 diagnosed prevalent cases in 2014 to 17,276,030 diagnosed prevalent cases in 2024 at an AGR of 1.43% during the forecast period.

Scope

- The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for hand OA, knee OA, and hip OA in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). The report also includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of hand OA, knee OA, and hip OA segmented by age and sex in these markets.
- The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global OA market.
- Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.

Table Of Contents

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 12
3 Epidemiology 13
3.1 Disease Background 13
3.2 Risk Factors and Comorbidities 14
3.3 Global Trends 16
3.3.1 Total Prevalence of OA - 7MM 16
3.3.2 Diagnosed Prevalence of OA - 7MM 16
3.4 Forecast Methodology 20
3.4.1 Sources Used 27
3.4.2 Sources Not Used 32
3.4.3 Forecast Assumptions and Methods 33
3.5 Epidemiological Forecast for OA (2014-2024) 38
3.5.1 Total Prevalent Cases 38
3.5.2 Diagnosed Prevalent Cases 53
3.5.3 Severity of Knee OA based on KL Grades 69
3.6 Discussion 70
3.6.1 Epidemiological Forecast Insight 70
3.6.2 Limitations of the Analysis 71
3.6.3 Strengths of the Analysis 72
4 Appendix 73
4.1 Bibliography 73
4.2 About the Authors 77
4.2.1 Epidemiologists 77
4.2.2 Reviewers 77
4.2.3 Global Director of Therapy Analysis and Epidemiology 78
4.2.4 Global Head of Healthcare 79
4.3 About GlobalData 80
4.4 About EpiCast 80
4.5 Disclaimer 81

1.1 List of Tables
Table 1: Hand, Knee, and Hip OA Severity Scoring System Using the Kellgren Lawrence Scale 14
Table 2: Risk Factors and Comorbidities for OA 15
Table 3: Global Estimates for the Diagnosed Prevalence of OA 19
Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast for Hand OA Total Prevalent Cases 21
Table 5: 7MM, Sources of Epidemiological Data Used for the Forecast of Knee OA Total Prevalent Cases 22
Table 6: 7MM, Sources of Epidemiological Data Used for the Forecast of Hip OA Total Prevalent Cases 23
Table 7: 7MM, Sources of Epidemiological Data Used for the Forecast of Hand OA Diagnosed Prevalent Cases 24
Table 8: 7MM, Sources of Epidemiological Data Used for the Forecast of Knee OA Diagnosed Prevalent Cases 25
Table 9: 7MM, Sources of Epidemiological Data Used for the Forecast of Hip OA Diagnosed Prevalent Cases 26
Table 10: 7MM, Sources of Epidemiological Data Used for the Severity* of Knee OA based on KL Grade 27
Table 11: 7MM, Total Prevalent Cases of Hand OA, Both Sexes, Ages ?20 Years, N, 2014-2024 38
Table 12: 7MM, Age-Specific Total Prevalent Cases of Hand OA, Both Sexes, N (Row %), 2014 40
Table 13: 7MM, Sex-Specific Total Prevalent Cases of Hand OA, Ages ?20 Years, N (Row %), 2014 42
Table 14: 7MM, Total Prevalent Cases of Knee OA, Both Sexes, Ages ?20 Years, N, 2014-2024 44
Table 15: 7MM, Age-Specific Total Prevalent Cases of Knee OA, Both Sexes, N (Row %), 2014 45
Table 16: 7MM, Sex-Specific Total Prevalent Cases of Knee OA, Ages ?20 Years, N (Row %), 2014 47
Table 17: 7MM, Total Prevalent Cases of Hip OA, Both Sexes, Ages ?20 Years, N, 2014-2024 49
Table 18: 7MM, Age-Specific Total Prevalent Cases of Hip OA, Both Sexes, N (Row %), 2014 50
Table 19: 7MM, Sex-Specific Total Prevalent Cases of Hip OA, Ages ?20 Years, N (Row %), 2014 52
Table 20: 7MM, Diagnosed Prevalent Cases of Hand OA, Both Sexes, Ages ?20 Years, N, 2014-2024 54
Table 21: 7MM, Age-Specific Diagnosed Prevalent Cases of Hand OA, Both Sexes, N (Row %), 2014 55
Table 22: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hand OA, Ages ?20 Years, N (Row %), 2014 57
Table 23: 7MM, Diagnosed Prevalent Cases of Knee OA, Both Sexes, Ages ?20 Years, N, 2014-2024 59
Table 24: 7MM, Age-Specific Diagnosed Prevalent Cases of Knee OA, Both Sexes, N (Row %), 2014 60
Table 25: 7MM, Sex-Specific Diagnosed Prevalent Cases of Knee OA, Ages ?20 Years, N (Row %), 2014 62
Table 26: 7MM, Diagnosed Prevalent Cases of Hip OA, Both Sexes, Ages ?20 Years, N, 2014-2024 64
Table 27: 7MM, Age-Specific Diagnosed Prevalent Cases of Hip OA, Both Sexes, N (Row %), 2014 66
Table 28: 7MM, Sex-Specific Diagnosed Prevalent Cases of Hip OA, Ages ?20 Years, N (Row %), 2014 68
Table 29: 7MM, Total and Diagnosed Prevalent Cases of Knee OA by Severity based on KL Grades, Both Sexes, Ages ?20 Years, N, 2014 70

1.2 List of Figures
Figure 1: 7MM, Total Prevalent Cases of Hand OA, Both Sexes, Ages ?20 Years, N, 2014-2024 39
Figure 2: 7MM, Total Prevalent Cases of Hand OA by Age Group, Both Sexes, N, 2014 41
Figure 3: 7MM, Total Prevalent Cases of Hand OA by Sex, Ages ?20 Years, N, 2014 43
Figure 4: 7MM, Total Prevalent Cases of Knee OA, Both Sexes, Ages ?20 Years, N, 2014-2024 44
Figure 5: 7MM, Total Prevalent Cases of Knee OA by Age Group, Both Sexes, N, 2014 46
Figure 6: 7MM, Total Prevalent Cases of Knee OA by Sex, Ages ?20 Years, N, 2014 48
Figure 7: 7MM, Total Prevalent Cases of Hip OA, Both Sexes, Ages ?20 Years, N, 2014-2024 49
Figure 8: 7MM, Total Prevalent Cases of Hip OA by Age Group, Both Sexes, N, 2014 51
Figure 9: 7MM, Total Prevalent Cases of Hip OA by Sex, Ages ?20 Years, N, 2014 53
Figure 10: 7MM, Diagnosed Prevalent Cases of Hand OA, Both Sexes, Ages ?20 Years, N, 2014-2024 54
Figure 11: 7MM, Diagnosed Prevalent Cases of Hand OA by Age Group, Both Sexes, N, 2014 56
Figure 12: 7MM, Diagnosed Prevalent Cases of Hand OA by Sex, Ages ?20 Years, N, 2014 58
Figure 13: 7MM, Diagnosed Prevalent Cases of Knee OA, Both Sexes, Ages ?20 Years, N, 2014-2024 59
Figure 14: 7MM, Diagnosed Prevalent Cases of Knee OA by Age Group, Both Sexes, N, 2014 61
Figure 15: 7MM, Diagnosed Prevalent Cases of Knee OA by Sex, Ages ?20 Years, N, 2014 63
Figure 16: 7MM, Diagnosed Prevalent Cases of Hip OA, Both Sexes, Ages ?20 Years, N, 2014-2024 64
Figure 17: 7MM, Diagnosed Prevalent Cases of Hip OA by Age Group, Both Sexes, N, 2014 67
Figure 18: 7MM, Diagnosed Prevalent Cases of Hip OA by Sex, Ages ?20 Years, N, 2014 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune ...

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteoarthritis in 9 Major Markets Osteoarthritis (OA), also known as degenerative joint disease / degenerative arthritis, is an inflammation ...

Osteoarthritis  - Market Insights, Epidemiology and Market Forecast-2023

Osteoarthritis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Osteoarthritis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.